Salt CompositionYou Searched
Lyomit 2 Injection
United Biotech Pvt. Ltd.
₹129
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Pancreatic cancer / Breast cancer / Non-small cell lung cancer / Stomach cancer
Customers also bought
More About Lyomit
Benefits
In Pancreatic cancer : Pancreas are very essential for digestion of whatever you eat and also for metabolism of blood sugar levels as they produce the body�s natural insulin. This medicine will help to control pancreatic cancer, and will relieve the symptoms such as, lack of appetite or unexplained weight loss. Lyomit 2 Injection helps to stop the action of those chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and healthier life.In Breast cancer Lyomit 2 Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Lyomit 2 Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.In Non-small cell lung cancer
Side Effects
Side effects of Lyomit Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Lyomit Anemia (low number of red blood cells)Decreased white blood cell count Increased bleeding tendency Loss of appetite Nausea Vomiting Feeling of discomfort Low blood platelets Weight loss Rash
How to use
How to use Lyomit Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
How Lyomit Injection works Lyomit 2 Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
Not Safe: Consuming alcohol with Lyomit 2 Injection may lead to excessive drowsiness.
Lyomit 2 Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Lyomit 2 Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Lyomit 2 Injection may cause side effects which could affect your ability to drive.Lyomit 2 Injection may cause nausea and vomiting and thereby reduce your reaction times to such an extent that the ability to drive a motor vehicle is impaired.
Lyomit 2 Injection should be used with caution in patients with kidney disease. Dose adjustment of Lyomit 2 Injection may be needed. Doctor consultation is advised.Use of Lyomit 2 Injection is not recommended in patients with end-stage kidney disease.
Lyomit 2 Injection should be used with caution in patients with liver disease. Dose adjustment of Lyomit 2 Injection may be needed. Doctor consultation is advised.Use of Lyomit 2 Injection may not be recommended in some patients with liver disease.
Manufacturer Address
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044
References
Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1718-19
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 952
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 931-32
Central Drugs Standard Control Organisation (CDSCO) (26 Mar. 2019)
Mitomycin. BC Cancer Drug Manual; 1994 (26 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
